Periocular Basal Cell Carcinoma (BCC): Permanent vs. Frozen Section Pathological Control
A Randomized Clinical Trial in the Surgical Treatment of Basal Cell Carcinoma of the Eyelid: Surgical Excision With Frozen Section vs. Permanent Section Control
1 other identifier
interventional
290
1 country
1
Brief Summary
This study is an equivalency study designed as a randomized clinical trial. Patients with a biopsy proven nodular periocular basal cell carcinoma (BCC) who have agreed to have surgical excision will be eligible. Study patients will undergo surgical excision of the lesion and then be randomized to having frozen section or permanent section pathological control. For those patients randomized to permanent section control the sample will be sent to pathology and surgical reconstruction will be performed. Patients randomized to frozen section will have additional margins re-excised before reconstruction depending on the pathologic results. Tumor clearance rates after surgical excision will be compared between the two techniques as a primary study question. Patients will be followed long-term to determine recurrence rates in the two groups. The study is designed to determine if the two techniques are equivalent within a given margin of error with respect to outcome measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started Aug 2008
Longer than P75 for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 18, 2008
CompletedFirst Posted
Study publicly available on registry
April 22, 2008
CompletedStudy Start
First participant enrolled
August 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedJuly 12, 2011
July 1, 2011
4.3 years
April 18, 2008
July 11, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The proportion of BCC's that are pathologically clear of tumor cells in the permanent section group compared with the frozen section group (presumably clear for all patients).
1.5 years
Secondary Outcomes (1)
Clinical recurrence at 3 years
4.5 years
Study Arms (2)
1
ACTIVE COMPARATORPermanent Section Control
2
ACTIVE COMPARATORFrozen Section Control
Interventions
After surgical excision of the tumor, margins will be sent for permanent section pathologic control to determine if the tumor was completely excised
After surgical excision of the tumor, tumor edges will be analyzed by frozen section at the time of surgery. If tumor margins are positive with the frozen section, additional tissue will be excised and analyzed again. This process will be repeated until all tissue edges are clear of tumor. Finally, the area of tumor excision will be surgically reconstructed.
Eligibility Criteria
You may qualify if:
- years old or greater
- Diagnosed with clinically nodular BCC in the periocular region confirmed by tissue biopsy
- Agreeable and medically able to undergo surgical excision of the BCC
- Able to give informed consent and consent has been signed
- Able to return for all follow up visits
You may not qualify if:
- BCC greater than 2cm in diameter (based on clinical examination)
- Patient with a medical condition predisposing to multiple BCC's (ex. basal cell nevus syndrome)
- Recurrent BCC's (i.e. a BCC that has been treated previously by surgical or other modality and has recurred will not be eligible)
- Clinically aggressive morpheaform subtype of BCC
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hotel Dieu Hospital
Kingston, Ontario, K7L 5G2, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vladimir Kratky, MD, FRCSC
Department of Ophthalmology, Queen's University, Kingston, ON
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 18, 2008
First Posted
April 22, 2008
Study Start
August 1, 2008
Primary Completion
December 1, 2012
Study Completion
June 1, 2013
Last Updated
July 12, 2011
Record last verified: 2011-07